FDA guidance on off-label promotion and the state of the literature from sponsors

被引：21
|
作者：
Psaty, Bruce M. [1 ,2 ,3 ,4 ]
Ray, Wayne [5 ,6 ]
机构：
[1] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[2] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[3] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Educ & Res Therapeut, Nashville, TN 37212 USA
[6] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37203 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 299卷 / 16期
关键词：
D O I：
10.1001/jama.299.16.1949
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1949 / 1951
页数：3
相关论文
共 50 条
  • [1] FDA off-track on off-label drug promotion
    不详
    [J]. LANCET, 2007, 370 (9604): : 1976 - 1976
  • [2] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [3] Off-label promotion
    Kuehn, BM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06): : 673 - 673
  • [4] Off-label promotion: Is FDA's final guidance on industry-supported scientific and educational programs enforceable?
    Bass, IS
    Kalb, PE
    Berenson, BA
    [J]. FOOD AND DRUG LAW JOURNAL, 1998, 53 (02): : 193 - 212
  • [5] Off-label drug promotion
    不详
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
  • [6] Marketing off-label uses to physicians: FDA's draft (mis)guidance
    Gass, Andy
    Wilson, Jennifer
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2008, 8 (03): : 1 - 3
  • [7] From off-label prescribing towards a new FDA
    Tabarrok, Alex
    [J]. MEDICAL HYPOTHESES, 2009, 72 (01) : 11 - 13
  • [8] FDA SCRUTINIZES OFF-LABEL PROMOTIONS
    RANDALL, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01): : 11 - 11
  • [9] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    [J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [10] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
    Tanne, Janice Hopkins
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
12345